This post was originally published on this site

Building a leading gene therapy pipeline in under two years (and a lot of air miles): how to persevere and make the calls that matter. Throughout a career in business development I’ve sat at every seat at the negotiating table, but I count my experience building AVROBIO’s leading lentiviral vector (LV) ex vivo gene therapy pipeline asRead More »

The post Leave No Stone Unturned: A Pipeline Story appeared first on Atlas Venture.